secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001193125-26-108482
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics sets 2026 annual meeting for June 9
------------------------------------------------------

- Record date for voting is April 13, 2026; stockholders of record on that date are entitled to vote.
- Rule 14a-8 stockholder proposals must be received by March 26, 2026, which is 10 days after this filing.
- Definitive proxy statement will specify meeting time and location.
- Meeting is scheduled more than 30 days after the 2025 annual meeting, triggering the revised proposal deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312526108482/0001193125-26-108482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312526108482/d47103d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-108482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer